American Vietnamese Biotech Incorporation (HNX:AMV)
Vietnam · Delayed Price · Currency is VND 1,300.00
0.00 (0.00%)
At close: Jul 20, 2026
HNX:AMV Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -57,929 | -53,049 | -11,191 | 10,685 | 53,931 | 82,240 |
Depreciation & Amortization | 31,071 | 32,910 | 16,325 | 21,832 | 20,399 | 15,877 |
Other Amortization | 2,672 | - | 7,620 | - | - | - |
Loss (Gain) From Sale of Assets | -2,578 | -1,961 | -11,949 | -1,365 | -546.84 | - |
Other Operating Activities | 34,797 | 35,497 | 24,629 | 5,230 | 7,951 | 408.69 |
Change in Accounts Receivable | -19,133 | 252,997 | 410,074 | -121,671 | -496,320 | -258,575 |
Change in Inventory | -13,664 | -10,843 | 237,134 | -11,168 | 67,769 | -272,042 |
Change in Accounts Payable | 154,831 | 4,524 | 2,010 | -41,177 | 303.52 | -4,781 |
Change in Other Net Operating Assets | -849.74 | -1,280 | 253.04 | -223.42 | 310.58 | -562.38 |
Operating Cash Flow | 129,218 | 258,793 | 674,905 | -137,858 | -346,202 | -437,435 |
Operating Cash Flow Growth | -86.05% | -61.66% | - | - | - | - |
Capital Expenditures | -11,561 | -12,167 | -46,375 | -6,934 | -1,485 | -73,459 |
Sale of Property, Plant & Equipment | 352.2 | 352.2 | 2,519 | 10,708 | 13,492 | - |
Investment in Securities | 8,140 | -255,392 | -623,720 | 144,013 | - | - |
Other Investing Activities | 2,295 | 1,697 | 114.47 | - | 1,102 | 3,482 |
Investing Cash Flow | -268.72 | -265,004 | -685,396 | 109,102 | 8,209 | -69,860 |
Long-Term Debt Issued | - | - | 9,660 | - | - | 145,000 |
Long-Term Debt Repaid | - | -4,999 | -21,813 | -4,580 | -12,788 | -14,599 |
Net Debt Issued (Repaid) | -127,499 | -4,999 | -12,153 | -4,580 | -12,788 | 130,401 |
Issuance of Common Stock | - | - | - | - | 399,748 | 379,620 |
Common Dividends Paid | - | - | - | -875.44 | - | - |
Financing Cash Flow | -127,499 | -4,999 | -12,153 | -5,455 | 386,959 | 510,022 |
Net Cash Flow | 1,450 | -11,209 | -22,645 | -34,212 | 48,966 | 2,727 |
Free Cash Flow | 117,657 | 246,626 | 628,530 | -144,792 | -347,688 | -510,894 |
Free Cash Flow Growth | -86.62% | -60.76% | - | - | - | - |
Free Cash Flow Margin | 120.37% | 160.08% | 202.52% | -73.66% | -123.37% | -228.24% |
Free Cash Flow Per Share | 903.73 | 1882.84 | 4794.07 | -1104.39 | -3236.32 | -6069.36 |
Cash Interest Paid | 8,067 | 8,067 | 13,502 | 14,714 | 15,576 | 10,060 |
Cash Income Tax Paid | 587.29 | 27.04 | 299.34 | 2,307 | 0.11 | 487.17 |
Levered Free Cash Flow | - | 282,057 | 534,786 | -107,752 | -353,159 | -546,725 |
Unlevered Free Cash Flow | - | 293,643 | 547,067 | -93,156 | -340,466 | -535,398 |
Change in Working Capital | 121,185 | 245,398 | 649,471 | -174,240 | -427,937 | -535,960 |